Apple Watch

President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.

The Apple Watch Series 9 allows users to log and access healthcare data, and to control the Watch by double-tapping their index finger and thumb.

The company will first use the patent to combine the Apple Watch with Apple's new augmented reality headset Apple Vision Pro for closed loop AI-enabled treatment.

The Apple watchOS 10 will allow users to track their emotions and moods, connect with mental health resources and measure time spent outdoors to reduce the risk of myopia.

AmerisourceBergen will support the distribution of h2o's Apple Watch-enabled prescription digital therapeutic for Parkinson's disease monitoring. 

Consumers can earn rewards points, grocery coupons and discounts for closing their activity rings on their Apple Watch or iPhone.

The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.

The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.

The Patent Trial and Appeal Board determined three AliveCor patents regarding the detection of heart conditions like cardiac arrhythmias were unpatentable.

The Rhythm Evaluation for AntiCoagulaTion (REACT-AF) trial will study a "pill-in-pocket" method of stroke prevention for patients with atrial fibrillation. Some participants will monitor for AFib using an Apple Watch and take blood thinners as needed, instead of using the drug continuously.